1922-49-2 Usage
Uses
Used in Pharmaceutical Development:
(3beta,16beta,17alpha)-3-hydroxy-16,17-epoxypregn-5-en-20-one is used as a key intermediate in the development of pharmaceutical drugs due to its potential anti-inflammatory and immunosuppressive effects. These properties make it a candidate for treating conditions that involve inflammation and immune system dysregulation.
Used in Medical Research:
In the field of medical research, (3beta,16beta,17alpha)-3-hydroxy-16,17-epoxypregn-5-en-20-one serves as a subject of study to better understand its biological activities and potential applications in treating specific medical conditions. Ongoing research aims to uncover its full therapeutic potential and optimize its use in medicine.
Used in Drug Formulation:
(3beta,16beta,17alpha)-3-hydroxy-16,17-epoxypregn-5-en-20-one is utilized in drug formulation to create medications that can target inflammation and modulate immune responses. Its incorporation into drug formulations is driven by the need for effective treatments with minimal side effects.
Note: Since the provided materials do not specify different industries or detailed applications, the uses listed are general and based on the compound's described properties and potential. Further information would be required to provide industry-specific applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1922-49-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,9,2 and 2 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1922-49:
(6*1)+(5*9)+(4*2)+(3*2)+(2*4)+(1*9)=82
82 % 10 = 2
So 1922-49-2 is a valid CAS Registry Number.
1922-49-2Relevant academic research and scientific papers
Synthetic method for drug intermediate 5-pregnene-16alpha,17alpha-epoxy-3beta-ol-20-one
-
Paragraph 0012; 0014-0025, (2018/07/30)
The invention discloses a synthetic method for the drug intermediate 5-pregnene-16alpha,17alpha-epoxy-3beta-ol-20-one. The synthetic method comprises the following steps: adding 5-pregnene-16-hydroxy-17-bromo-3-methoxy-20-one and a sodium chloride solution into a reaction vessel, raising the temperature of the obtained solution, controlling a stirring speed, adding lead dioxide and a dodecanol solution and continuing a reaction; and then adding zinc benzoate powder, raising the temperature of the obtained solution, continuing the reaction, carrying out cooling, subjecting the solution to standing so as to realize layering of the solution, carrying out washing with a potassium sulfate solution, carrying out washing with a trichlorotoluene solution, then carrying out recrystallization in a triethylene glycol monomethyl ether solution, and then carrying out dehydration with a dehydrating agent to obtain finished 5-pregnene-16alpha,17alpha-epoxy-3beta-ol-20-one.
